BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 11906745)

  • 1. The worm in us - Caenorhabditis elegans as a model of human disease.
    Baumeister R; Ge L
    Trends Biotechnol; 2002 Apr; 20(4):147-8. PubMed ID: 11906745
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscular dystrophy: the worm turns to genetic disease.
    Chamberlain JS; Benian GM
    Curr Biol; 2000 Nov; 10(21):R795-7. PubMed ID: 11084353
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Ellwood RA; Piasecki M; Szewczyk NJ
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34063069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A Nematode Nobel Prize: Caenorhabditis elegans].
    Savel J; Clostre F
    Ann Pharm Fr; 2006 Sep; 64(5):291-307. PubMed ID: 17095949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [C. elegans as a model for human inherited degenerative diseases].
    Ségalat L; Néri C
    Med Sci (Paris); 2003 Dec; 19(12):1218-25. PubMed ID: 14691746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-species modeling of muscular dystrophy in Caenorhabditis elegans using patient-derived extracellular vesicles.
    Shalash R; Levi-Ferber M; Cohen C; Dori A; Brodie C; Henis-Korenblit S
    Dis Model Mech; 2024 Mar; 17(3):. PubMed ID: 38501170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases.
    Martinez-Finley EJ; Avila DS; Chakraborty S; Aschner M
    Metallomics; 2011 Mar; 3(3):271-9. PubMed ID: 21210060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nematode Caenorhabditis elegans: a versatile model for the study of proteotoxicity and aging.
    Volovik Y; Marques FC; Cohen E
    Methods; 2014 Aug; 68(3):458-64. PubMed ID: 24794346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans.
    Gaud A; Simon JM; Witzel T; Carre-Pierrat M; Wermuth CG; Ségalat L
    Neuromuscul Disord; 2004 Jun; 14(6):365-70. PubMed ID: 15145337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-structural time-course study in the C. elegans model for Duchenne muscular dystrophy highlights a crucial role for sarcomere-anchoring structures and sarcolemma integrity in the earliest steps of the muscle degeneration process.
    Brouilly N; Lecroisey C; Martin E; Pierson L; Mariol MC; Qadota H; Labouesse M; Streichenberger N; Mounier N; Gieseler K
    Hum Mol Genet; 2015 Nov; 24(22):6428-45. PubMed ID: 26358775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What do animal models have to tell us regarding Duchenne muscular dystrophy?
    Wells DJ; Wells KE
    Acta Myol; 2005 Dec; 24(3):172-80. PubMed ID: 16629050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochonic Acid 5 Improves Duchenne Muscular Dystrophy and Parkinson's Disease Model of
    Wu X; Nagasawa S; Muto K; Ueda M; Suzuki C; Abe T; Higashitani A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic suppression of phenotypes arising from mutations in dystrophin-related genes in Caenorhabditis elegans.
    Gieseler K; Grisoni K; Ségalat L
    Curr Biol; 2000 Sep; 10(18):1092-7. PubMed ID: 10996789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
    Link CD
    Exp Gerontol; 2006 Oct; 41(10):1007-13. PubMed ID: 16930903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of dystrobrevin delays locomotion defects and muscle degeneration in a dystrophin-deficient Caenorhabditis elegans.
    Gieseler K; Grisoni K; Mariol MC; Ségalat L
    Neuromuscul Disord; 2002 May; 12(4):371-7. PubMed ID: 12062255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delivery of Native Proteins into C. elegans Using a Transduction Protocol Based on Lipid Vesicles.
    Perni M; Aprile FA; Casford S; Mannini B; Sormanni P; Dobson CM; Vendruscolo M
    Sci Rep; 2017 Nov; 7(1):15045. PubMed ID: 29118344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical genetics unveils a key role of mitochondrial dynamics, cytochrome c release and IP3R activity in muscular dystrophy.
    Giacomotto J; Brouilly N; Walter L; Mariol MC; Berger J; Ségalat L; Becker TS; Currie PD; Gieseler K
    Hum Mol Genet; 2013 Nov; 22(22):4562-78. PubMed ID: 23804750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duchenne muscular dystrophy: stalled at the junction?
    Ségalat L; Anderson JE
    Eur J Hum Genet; 2005 Jan; 13(1):4-5. PubMed ID: 15483645
    [No Abstract]   [Full Text] [Related]  

  • 19. [Animal models of neurodegenerative diseases].
    Langui D; Lachapelle F; Duyckaerts C
    Med Sci (Paris); 2007 Feb; 23(2):180-6. PubMed ID: 17291428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscular degeneration in the absence of dystrophin is a calcium-dependent process.
    Mariol MC; Ségalat L
    Curr Biol; 2001 Oct; 11(21):1691-4. PubMed ID: 11696327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.